Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis : an individual participant data meta-analysis
© 2023. BioMed Central Ltd., part of Springer Nature..
BACKGROUND: A previous individual participant data meta-analysis (IPD-MA) of antibiotics for adults with clinically diagnosed acute rhinosinusitis (ARS) showed a marginal overall effect of antibiotics, but was unable to identify patients that are most likely to benefit from antibiotics when applying conventional (i.e. univariable or one-variable-at-a-time) subgroup analysis. We updated the systematic review and investigated whether multivariable prediction of patient-level prognosis and antibiotic treatment effect may lead to more tailored treatment assignment in adults presenting to primary care with ARS.
METHODS: An IPD-MA of nine double-blind placebo-controlled trials of antibiotic treatment (n=2539) was conducted, with the probability of being cured at 8-15 days as the primary outcome. A logistic mixed effects model was developed to predict the probability of being cured based on demographic characteristics, signs and symptoms, and antibiotic treatment assignment. Predictive performance was quantified based on internal-external cross-validation in terms of calibration and discrimination performance, overall model fit, and the accuracy of individual predictions.
RESULTS: Results indicate that the prognosis with respect to risk of cure could not be reliably predicted (c-statistic 0.58 and Brier score 0.24). Similarly, patient-level treatment effect predictions did not reliably distinguish between those that did and did not benefit from antibiotics (c-for-benefit 0.50).
CONCLUSIONS: In conclusion, multivariable prediction based on patient demographics and common signs and symptoms did not reliably predict the patient-level probability of cure and antibiotic effect in this IPD-MA. Therefore, these characteristics cannot be expected to reliably distinguish those that do and do not benefit from antibiotics in adults presenting to primary care with ARS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Diagnostic and prognostic research - 7(2023), 1 vom: 05. Sept., Seite 16 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hoogland, Jeroen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute rhinosinusitis |
---|
Anmerkungen: |
Date Revised 21.11.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1186/s41512-023-00154-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361650310 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361650310 | ||
003 | DE-627 | ||
005 | 20231226085605.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s41512-023-00154-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1205.xml |
035 | |a (DE-627)NLM361650310 | ||
035 | |a (NLM)37667327 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hoogland, Jeroen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis |b an individual participant data meta-analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
520 | |a BACKGROUND: A previous individual participant data meta-analysis (IPD-MA) of antibiotics for adults with clinically diagnosed acute rhinosinusitis (ARS) showed a marginal overall effect of antibiotics, but was unable to identify patients that are most likely to benefit from antibiotics when applying conventional (i.e. univariable or one-variable-at-a-time) subgroup analysis. We updated the systematic review and investigated whether multivariable prediction of patient-level prognosis and antibiotic treatment effect may lead to more tailored treatment assignment in adults presenting to primary care with ARS | ||
520 | |a METHODS: An IPD-MA of nine double-blind placebo-controlled trials of antibiotic treatment (n=2539) was conducted, with the probability of being cured at 8-15 days as the primary outcome. A logistic mixed effects model was developed to predict the probability of being cured based on demographic characteristics, signs and symptoms, and antibiotic treatment assignment. Predictive performance was quantified based on internal-external cross-validation in terms of calibration and discrimination performance, overall model fit, and the accuracy of individual predictions | ||
520 | |a RESULTS: Results indicate that the prognosis with respect to risk of cure could not be reliably predicted (c-statistic 0.58 and Brier score 0.24). Similarly, patient-level treatment effect predictions did not reliably distinguish between those that did and did not benefit from antibiotics (c-for-benefit 0.50) | ||
520 | |a CONCLUSIONS: In conclusion, multivariable prediction based on patient demographics and common signs and symptoms did not reliably predict the patient-level probability of cure and antibiotic effect in this IPD-MA. Therefore, these characteristics cannot be expected to reliably distinguish those that do and do not benefit from antibiotics in adults presenting to primary care with ARS | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acute rhinosinusitis | |
650 | 4 | |a Antibiotic treatment | |
650 | 4 | |a Individual participant data meta-analysis | |
650 | 4 | |a Individualized treatment effect | |
650 | 4 | |a Prediction | |
650 | 4 | |a Randomized controlled trial | |
700 | 1 | |a Takada, Toshihiko |e verfasserin |4 aut | |
700 | 1 | |a van Smeden, Maarten |e verfasserin |4 aut | |
700 | 1 | |a Rovers, Maroeska M |e verfasserin |4 aut | |
700 | 1 | |a de Sutter, An I |e verfasserin |4 aut | |
700 | 1 | |a Merenstein, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Kaiser, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Liira, Helena |e verfasserin |4 aut | |
700 | 1 | |a Little, Paul |e verfasserin |4 aut | |
700 | 1 | |a Bucher, Heiner C |e verfasserin |4 aut | |
700 | 1 | |a Moons, Karel G M |e verfasserin |4 aut | |
700 | 1 | |a Reitsma, Johannes B |e verfasserin |4 aut | |
700 | 1 | |a Venekamp, Roderick P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic and prognostic research |d 2017 |g 7(2023), 1 vom: 05. Sept., Seite 16 |w (DE-627)NLM280120354 |x 2397-7523 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2023 |g number:1 |g day:05 |g month:09 |g pages:16 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s41512-023-00154-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2023 |e 1 |b 05 |c 09 |h 16 |